MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 195 filers reported holding MEDICINES CO in Q3 2018. The put-call ratio across all filers is 1.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $5,755,000 | -83.9% | 115,100 | -88.3% | 1.35% | -81.9% |
| Q2 2019 | $35,844,000 | -66.1% | 982,831 | -74.0% | 7.50% | -67.6% |
| Q1 2019 | $105,616,000 | +46.0% | 3,778,742 | 0.0% | 23.17% | +1.6% |
| Q4 2018 | $72,325,000 | -36.0% | 3,778,742 | 0.0% | 22.80% | -24.4% |
| Q3 2018 | $113,022,000 | -18.5% | 3,778,742 | 0.0% | 30.15% | +33.9% |
| Q2 2018 | $138,680,000 | +24.8% | 3,778,742 | +12.0% | 22.51% | -50.1% |
| Q1 2018 | $111,119,000 | +32.2% | 3,373,397 | +9.7% | 45.08% | -8.4% |
| Q4 2017 | $84,080,000 | -40.8% | 3,075,302 | -19.8% | 49.24% | -33.3% |
| Q3 2017 | $142,012,000 | +7.3% | 3,833,999 | +10.1% | 73.83% | -11.5% |
| Q2 2017 | $132,340,000 | -29.4% | 3,481,699 | -9.2% | 83.44% | -4.5% |
| Q1 2017 | $187,482,000 | – | 3,833,999 | – | 87.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |